Front Oncol October 2022 PMID 36353530

Strategies in activating lymphatic system to promote lymph flow on lymphedema symptoms in breast cancer survivors: A randomized controlled trial.

Xinwen Du, Yuan Li, Lan Fu, Huaying Chen, Xiaoxia Zhang, Yuping Shui, Aihua Zhang, Xianqiong Feng, Mei Rosemary Fu

Download social card

Mentions

5
Peak: 3 in Jan 2024
across 3 sources since Nov 2022

Extended reach

586
potential audience

Total likes

9

Video views

356

Mentions per month

Nov 2022 – Jul 2024

Where it's discussed

  • YouTube3 videos
  • X / Twitter1 posts
  • News1 articles

AI synopsis

What people are saying

The discussions commonly reference the positive outcomes of the TOLF program, such as reduced pain and improved daily functioning, using words like 'significant improvement' and 'potentially transformative.' The tone is generally supportive but modest, reflecting a recognition of its clinical relevance without overhyping, which aligns with the moderate scores assigned.

AgreementModerate agreement

Most discussions seem to acknowledge and support the findings of the trial, emphasizing the benefits of the TOLF program for managing lymphedema symptoms.

InterestModerate interest

The discussions show moderate interest, with many posts highlighting aspects of the intervention but not deeply exploring the broader implications.

EngagementModerate engagement

Several posts discuss specific elements like self-management strategies and clinical outcomes, indicating a genuine level of engagement.

ImpactModerate impact

Participants suggest that the study could influence future treatment approaches, though some posts are more tentative about its real-world adoption.

Abstract in brief

  • The TOLF program is an intervention designed to help breast cancer survivors manage lymphedema symptoms by teaching self-management strategies that activate the lymphatic system and promote lymph flow, aiming to reduce pain, severity, and impact on daily life.
  • In a 3-month randomized clinical trial with 92 participants, those using the TOLF program experienced significantly greater improvements in symptom number, severity, and daily functioning compared to a control group, demonstrating its potential effectiveness.
  • Both groups improved over time, but the group following the TOLF program showed notably better outcomes, highlighting the benefits of early self-management interventions in reducing lymphedema symptoms and improving quality of life.

Top posts

Most liked on X and Bluesky
painmanwise
@painmanwise · X

Strategies in activating lymphatic system to promote lymph flow on lymphedema symptoms in breast cancer survivors: A randomized controlled trial https://t.co/0ElcEwF1D0

Nov 10, 2022 · 221 followers View post →

All mentions

painmanwise
@painmanwise · X

Strategies in activating lymphatic system to promote lymph flow on lymphedema symptoms in breast cancer survivors: A randomized controlled trial https://t.co/0ElcEwF1D0

Nov 10, 2022 · 221 followers View post →
Lymphatic pain in breast cancer survivors: An overview of the ...
News

https://doi.org/10.3389/fonc.2022.1015387. 28. Fu MR, Rosedale M. Breast cancer survivors' experiences of lymphedema-related symptoms. J ...

Jul 1, 2024 View →